A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-To-Severe Psoriasis
figureposted on 2020-08-18, 09:23 authored by Emily K. Haque, Aaminah Azhar, John Corbett, Jillian Frieder, Xuan Wang, Alan Menter
Article full text
The above summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.